Curated Wealth Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Curated Wealth Partners’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Buy	+39,352	New	+$1.89M	0.07%	268

Other funds holding SUPN

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

Curated Wealth Partners's SUPN Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 39,352 shares worth $504K. The stake represents 0.07% of the portfolio and ranks #268 among its holdings.

27 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Curated Wealth Partners held 39,352 shares of Supernus Pharmaceuticals worth $504K as of Q2 2026.
Supernus Pharmaceuticals was a new Curated Wealth Partners position in Q2 2026.
Supernus Pharmaceuticals made up 0.07% of Curated Wealth Partners's portfolio in Q2 2026, its #268 holding.
27 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.